Meeting
2019 Gastrointestinal Cancers Symposium
Predictors of treatment response in colorectal high-grade neuroendocrine carcinomas (HGNEC): A single institution experience.
Authors
Virginia Corbett
Memorial Sloan Kettering Cancer Center, New York, NY
Virginia Corbett , Nitya Prabhakar Raj , Virginia Kelly , Diane Lauren Reidy
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 690)
DOI
10.1200/JCO.2019.37.4_suppl.690
Abstract #
690
Poster Bd #
N15
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Exploring systemic treatment approaches for advanced pure large cell neuroendocrine carcinoma (LCNEC): A multicenter retrospective analysis.
First Author: Amin Nassar
Poster
2024 ASCO Annual Meeting
Development of clinically accessible nomograms to predict risk of brain metastases at baseline and follow-up in patients with non-small cell lung cancer.
First Author: Alireza Mansouri
Poster
2024 ASCO Gastrointestinal Cancers Symposium
High-resolution transcriptional signature to predict survival benefit in colorectal cancer (CRC) treated with EGFR inhibitors (EGFRi) independent of RAS/BRAF mutation status or tumor sidedness.
First Author: Ramya Thota
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Clinical characteristics and outcomes of patients with metastatic colitis-associated cancer treated with EGFR inhibitors.
First Author: Celine Yeh